Interstitial Lung Disease Research Unit Biobank

University of Kansas Medical Center Interstitial Lung Disease Research Unit (ILDRU) Biobank

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05392881

Acronym

ILDRU

Enrollment

1000

Registered

2022-05-26

Start date

2021-08-09

Completion date

2032-03-01

Last updated

2026-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypersensitivity Pneumonitis, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Pulmonary Fibrosis, Sarcoidosis

Keywords

Interstitial Lung Disease, Sarcoidosis, Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Hypersensitivity Pneumonitis

Brief summary

Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.

Detailed description

The University of Kansas ILD and Rare Lung Disease clinic sees hundreds of new patients per year. The investigators would like to leverage this resource to develop an Interstitial Lung Disease Research Unit (ILDRU) repository and database to help develop new methods for early diagnosis, uncover underlying genetic and environmental risk factors, as well as potential treatment targets in the broad range of interstitial lung diseases and rare lung diseases (RLD).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP) 2. The participant is being followed for the presence of autoimmune disease, ILD or other rare lung diseases at TUKHS. 3. The participant is ≥ 18 years of age. 4. The participant has signed an approved consent for this study (living patients only)

Design outcomes

Primary

Measure	Time frame
Collect clinically obtained data for patients with ILD, RLD and risk for ILD/RLD to support research.	Enrollment to Year 10
Establish a collection of biological samples from patients with ILD, RLD and subjects at risk for ILD.	Enrollment to Year 10
Correlate biological samples with individual longitudinal clinical data.	Enrollment to Year 10
Provide biological samples to researchers performing studies in ILD and RLD.	Enrollment to Year 10
Collect historical data and imaging from deceased patients with ILD.	Enrollment to Year 10

Countries

United States

Contacts

CONTACTKimberly Donnelly, Ph.D.

kdonnelly@kumc.edu913-588-6067

PRINCIPAL_INVESTIGATORScott Matson, M.D.

University of Kansas Medical Center

Outcome results